Physician profile
Shane P Smith
NPI 1093177198
$3,986.92
in general payments reported to CMS, 2019-2025
15 companies · $3,114 in 2025
The $3,114 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $873 · 2025: $3,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,406 · Travel and Lodging: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,406.11 |
| Travel and Lodging | $1,580.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,128.35 | 2024-2025 | Impella |
| Bolton Medical INC | $486.59 | 2025 | |
| Edwards Lifesciences Corporation | $407.06 | 2024-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Atricure, INC. | $364.26 | 2024 | |
| Ethicon US, LLC | $177.28 | 2025 | Vistaseal, Stratafix |
| Zimmer Biomet Holdings, INC. | $141.89 | 2024 | Ribfix Blu Advantage |
| Baxter Healthcare | $53.98 | 2024-2025 | Preveleak |
| Merck Sharp & Dohme LLC | $46.53 | 2025 | Keytruda, Keytruda Qlex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.39 | 2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $34.70 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $28.30 | 2025 | |
| Left Coast Surgical INC | $27.22 | 2025 | |
| Octapharma USA, INC. | $18.37 | 2025 | Fibryga |
| Artivion, INC. | $14.61 | 2025 | Amds-Ascyrus Medical, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Medtronic, INC. | $14.39 | 2024 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.